Clinical trial

Comparison of Plasma Exchange and Conservative Management in Non-severe Acute Hypertriglyceridemic Pancreatitis With Mildly Elevated Triglycerides

Name
HiperlipPankr
Description
To compare effectiveness in reducing triglycerides between daily plasma exchange and glucose+insulin infusion in patients with non-severe acute hypertriglyceridemic pancreatitis with mildly elevated triglycerides
Trial arms
Trial start
2016-06-01
Estimated PCD
2020-08-01
Trial end
2020-08-01
Status
Completed
Treatment
plasma exchange
see arm description
Arms:
plasma exchange
conservative treatment
see arm description
Arms:
conservative treatment
Other names:
glucose and insulin
Size
22
Primary endpoint
decrease in triglycerides
within first 24 h after admission
Eligibility criteria
Inclusion Criteria: * mild acute hypertriglyceridemic pancreatitis * triglycerides \>15 but \< 40 mmol/l Exclusion Criteria: * pregnancy * severe course of pancreatitis
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 22, 'type': 'ACTUAL'}}
Updated at
2023-11-30

1 organization

1 product

1 indication